TrialSpark, which wants to leverage its clinical trials management software into drug discovery, closed $156M Series C at a $1B+ valuation earlier this year (Emma Court/Bloomberg)

Emma Court / Bloomberg:
TrialSpark, which wants to leverage its clinical trials management software into drug discovery, closed $156M Series C at a $1B+ valuation earlier this year  —  - TrialSpark expands from clinical trials into developing drugs  — Company raised $156 million, is valued at more than $1 billion



from Techmeme https://ift.tt/3usrF0k

Comments

Popular posts from this blog

Microsoft says it has no plans to add more backward compatible titles for Xbox One, but says Project Scarlett will run games from all four Xbox generations (Tom Warren/The Verge)

An in-depth look at Mike Speiser's investment playbook at Sutter Hill Ventures, who as a founding investor incubated Snowflake Computing as an interim CEO (Kevin/kwokchain)

Indian neobank Jupiter raises a $86M Series C at a $711M valuation, up from ~$300M in August, as it prepares to launch lending and wealth management services (Manish Singh/TechCrunch)